By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Transgenomic, Inc. 

12325 Emmett Street

Omaha  Nebraska  68107  U.S.A.
Phone: 402-738-5480 Fax: 402-733-1932



Company News
Transgenomic, Inc. (TBIO) Unveils The First Rapid Turnaround Liquid Biopsy Metastatic Breast Cancer Panel At AACR 2016 Annual Meeting 4/19/2016 12:01:20 PM
Transgenomic, Inc. (TBIO) Reports Full Year 2015 Financial Results 4/15/2016 9:02:28 AM
Transgenomic, Inc. (TBIO) To Hold Full Year Financial Results Conference Call On April 14, 2016 At 5:00 PM ET 4/14/2016 10:37:18 AM
Transgenomic, Inc. (TBIO) To Present Data Confirming Utility Of ICE COLD-PCR Liquid Biopsy Technology At AACR 2016 Annual Meeting 3/29/2016 10:24:26 AM
Transgenomic, Inc. (TBIO) Launches First Commercially Available Assay For Ultra Low Level Detection Of EGFR C797S Mutations That Predict Resistance To Third Generation Kinase Therapies For Lung Cancer 3/18/2016 10:12:24 AM
Transgenomic, Inc. (TBIO) Launches New MX-ICP Liquid Biopsy Tests for Comprehensive Detection of Colorectal and Melanoma Tumor Mutations 3/10/2016 11:11:16 AM
Transgenomic, Inc. (TBIO) Highlights Unique Advantages Of Multiplexed ICE COLD-PCR At Personalized Medicine World Conference 1/26/2016 10:35:14 AM
Transgenomic, Inc. (TBIO) Launches New MX-ICP Panels For Liquid Biopsy Detection Of RAS And PIK3CA Tumor Mutations 1/19/2016 10:25:38 AM
Transgenomic, Inc. (TBIO) Announces Private Placement Financing 1/11/2016 2:17:55 PM
Transgenomic, Inc. (TBIO) Announces Conversion Of Series A and B Preferred Securities And Extension Of Loan Maturity Date 1/11/2016 2:16:50 PM